Uncategorized
Dicerna Announces Late-Breaking Data from the PHYOX Phase 1 Clinical Trial of DCR-PHXC Will Be Presented at ASN Kidney Week 2018
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dicerna announced that late-breaking data from the PHYOX Phase 1 trial of DCR-PHXC for the treatment of PH will be presented at ASN Kidney Week 2018.